Irradiation impairment of umami taste in patients with head and neck cancer

Shi, Haibo; Masuda, Mitsuharu; Umezaki, Toshiro; Kuratomi, Yuichiro; Kumamoto, Y; Yamamoto, Tomoya; Komiyama, S.

doi:10.1016/j.anl.2004.05.002

Cited by 68 publications

(43 citation statements)

References 35 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This is followed by general abnormal taste and a reduction in taste acuity. 199,201,207,[209][210][211][212][213] Umami declines during the third week of RT. After RT, taste sensitivity usually recovers within several months after the resolution of mucosal damage.…”

Section: Taste Alterations In Cancermentioning

confidence: 99%

Oral complications of cancer and cancer therapy

Epstein

Thariat

Bensadoun

et al. 2012

CA A Cancer J Clinicians

412

356

View full text Add to dashboard Cite

Answer questions and earn CME/CNEOral complications resulting from cancer and cancer therapies cause acute and late toxicities that may be underreported, underrecognized, and undertreated. Recent advances in cancer treatment have led to changes in the incidence, nature, and severity of oral complications. As the number of survivors increases, it is becoming increasingly recognized that the aggressive management of oral toxicities is needed to ensure optimal long‐term oral health and general well‐being. Advances in care have had an impact on previously recognized oral complications and are leading to newly recognized adverse effects. Here, the authors briefly review advances in cancer therapy, including recent advances in surgery, oral care, radiation therapy, hematopoietic cell transplantation, and medical oncology; describe how these advances affect oral health; and discuss the frequent and/or severe oral health complications associated with cancer and cancer treatment and their effect upon long‐term health. Although some of the acute oral toxicities of cancer therapies may be reduced, they remain essentially unavoidable. The significant impact of long‐term complications requires increased awareness and recognition to promote prevention and appropriate intervention. It is therefore important for the primary oncologist to be aware of these complications so that appropriate measures can be implemented in a timely manner. Prevention and management is best provided via multidisciplinary health care teams, which must be integrated and communicate effectively in order to provide the best patient care in a coordinated manner at the appropriate time. CA Cancer J Clin 2012. © 2012 American Cancer Society.

show abstract

Section: Taste Alterations In Cancermentioning

confidence: 99%

Oral complications of cancer and cancer therapy

Epstein

Thariat

Bensadoun

et al. 2012

CA A Cancer J Clinicians

412

356

View full text Add to dashboard Cite

show abstract

“…Several published studies have examined the influence of cancer treatment on the sense of taste by measuring taste in this way [13][14][15][16][17][18]. The authors state in their methodology that, "Dysgeusia was assessed by the presence (Y/N) or grade when available."…”

mentioning

confidence: 99%

A matter of taste: making the distinction between taste and flavor is essential for improving management of dysgeusia

Boltong

Keast

Aranda

2011

Support Care Cancer

View full text Add to dashboard Cite

“…[6] The following sequence was followed for taste recognition threshold, i.e., Umami, followed by salt, sweet, sour, and bitter taste solution. [7] 1. Umami Mumbai.…”

Section: Determination Of Taste Thresholdmentioning

confidence: 99%

Altered taste threshold in chronic Type 2 diabetes mellitus

Latha¹,

Chandrashekar²,

Puranik³

2017

Natl J Physiol Pharm Pharmacol

View full text Add to dashboard Cite

Background: "Taste" is one of our basic senses. The prevalence of hypogeusia or ageusia is much more than what we are aware of, and hence it is addressed to a lesser extent. Diabetes mellitus (DM) is one such disease, which majorly contributes to the burden of taste dysfunction. Aims and Objectives: We have undertaken the present study to test and compare taste threshold in these patients with age and sex-matched healthy individuals. Materials and Methods: Sixty normal subjects with no DM were taken as controls and 60 known cases of Type 2 DM patients were taken as subjects in the present study. Taste threshold tests were performed in both these groups and were compared. Result: Chemical gustometry tests for five primary taste sensation were performed, it was observed that taste threshold for sweet and salty taste was higher and statistically significant (P < 0.01) in Type 2 diabetic patients compared to the control group. However, it was not significantly different for other taste modalities sour, bitter, and umami. Conclusion: Taste dysfunction was evident in Type 2 diabetic patients. The NJPPP_8(4)_27_RA increased taste threshold is specific, affecting salt and sweet modality mainly. Dysfunction of taste sensation should be detected in diabetics by screening. Measures to improve the food intake and supplementation for nutritional deficiencies can be given priority in diabetics.

show abstract

Irradiation impairment of umami taste in patients with head and neck cancer

Cited by 68 publications

References 35 publications

Oral complications of cancer and cancer therapy

Oral complications of cancer and cancer therapy

A matter of taste: making the distinction between taste and flavor is essential for improving management of dysgeusia

Altered taste threshold in chronic Type 2 diabetes mellitus

Contact Info

Product

Resources

About